Amneal - About the company
Amneal is a public company based in Bridgewater (United States), founded in 2002 by Chirag Patel. It operates as a Manufacturer of generics formulations. Amneal has raised an undisclosed amount in funding. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Biological E.
Company Details
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
- Website
- amneal.com
- Email ID
- *****@amneal.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2002
Location
Bridgewater, United States
Stage
Public
Latest Funding Round
Ranked
6th among 198 active competitors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
350 as on Mar 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Amneal
Amneal is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
AMNEAL PHARMACEUTICALS, INC. CIN: 1723128 , United States, Active | Oct 03, 2017 | $1B+ (As on Dec 31, 2025) | - | - |
Amneal Pharmaceuticals, Llc CIN: 262478140 , United States, Active | Dec 31, 1999 | - | 1626 (As on Dec 31, 2016) | - |
Amneal Pharmaceuticals Llc CIN: 3809030 , United States, Active | - | 2394 (As on Dec 31, 2018) | - |
Amneal's IPO details
Amneal got listed on Jan 20, 2009.
Click here to take a look at Amneal's IPO in detail
Sign up to download Amneal's company profile
Amneal's funding and investors
Amneal has raised funding over 3 rounds. Its first funding round was on 2005. Its latest funding round was a Post IPO round on Nov 16, 2018 for $*****. 1 investor participated in its latest round. Amneal has 4 institutional investors.
Here is the list of recent funding rounds of Amneal:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 16, 2018 | 7489251 | Post IPO | 9776921 | 3973174 | 7752176 | 3930284 |
Feb 10, 2015 | 2433866 | Conventional Debt | 4621159 | 9623916 | 1809311 | |
2005 | 5251 | Series A | 1743 | 9808 | 4349 |
View details of Amneal's funding rounds and investors
Amneal's founders and board of directors
Founder? Claim ProfileThe founders of Amneal is Chirag Patel.
Here are the details of Amneal's key team members:
- Chirag Patel: Co-CEO & ex-Co-Founder of Amneal. Contact Info: 1 email address
View details of Amneal's Founder profiles and Board Members
Amneal's employee count trend
Amneal has 350 employees as of Mar 26. Here is Amneal's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Amneal's Competitors and alternates
Top competitors of Amneal include Bayer, Wockhardt and Biological E. Here is the list of Top 10 competitors of Amneal, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
3rd | Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
4th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
5th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
6th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
7th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
8th | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | - | 67/100 | ||
9th | Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th | Dr. Reddy's Laboratories 1984, Hyderabad (India), Public | Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health | - | 65/100 |
Looking for more details on Amneal's competitors? Click here to see the top ones
Amneal's Investments and acquisitions
Amneal has not made any investments yet. Amneal has made 7 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 22, 2026 | Acquisition | 2010 | Piscataway (United States) | |
Nov 02, 2021 | Acquisition | 2017 | Ahmedabad (India) | |
Jan 12, 2021 | Acquisition | 2020 | Bridgewater (United States) |
See all acquisitions by Amneal
Reports related to Amneal
Here is the latest report on Amneal's geography:
News related to Amneal
Media has covered Amneal for a total of 27 events in the last 1 year, 10 of them have been about company updates and 1 about partnerships.
•
Amneal Pharmaceuticals to Report Third Quarter 2026 Results on November 3GlobeNewswire•Oct 08, 2026•Amneal
•
Amneal Pharmaceuticals Announces FDA Approval and Launch of Lanreotide InjectionGlobeNewswire•Sep 19, 2026•Amneal
•
Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Jason Daly Sells 6,613 SharesThecerbatgem•Aug 14, 2026•Amneal
•
Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Jason Daly Sells 210,000 SharesThecerbatgem•Aug 14, 2026•Amneal
•
Amneal Pharmaceuticals finalizes $1.1 billion acquisition of Kashiv BiosciencesNJBIZ•Aug 11, 2026•Amneal, Kashiv BioSciences
•
•
Amneal Pharmaceuticals, Inc. Reports Second Quarter 2026 Financial ResultsGlobeNewswire•Jul 30, 2026•Amneal
•
Amneal Pharmaceuticals Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional StrengthsGlobeNewswire•Jul 17, 2026•Amneal
•
Alkermes Terminates VIVITROL Authorized Generic Supply Agreement With Amneal Without Penalties - AlkermesBenzinga•Jul 08, 2026•Alkermes, Amneal
•
Are you a Founder ?
FAQs about Amneal
Explore our recently published companies
- GreenFlow Solutions - Canada based, 2024 founded, Unfunded company
- Italfarmaco - Milan based, 1938 founded, Unfunded company
- Terrolight Pharmaceuticals - Jodhpur based, 2016 founded, Deadpooled company
- Digital Vision Pharma - Sirmaur based, 2009 founded, Unfunded company
- Celltrion Pharm - Cheongju-si based, 2000 founded, Public company
- Allied Patients - Kailua based, 2018 founded, Deadpooled company